Re:Stanford cancels in-person classes for rest of the quarter
by Ozzie_osman on Saturday March 07, 2020 @02:13AM
(#22510289)
I'd actually be curious. Is it the type of thing where a vaccine ends it? Or will it be like the flu where it's always mutating and so the vaccine helps but it's still always out there in some form.
[ Parent
| on HN ]
Re:Stanford cancels in-person classes for rest of the quarter
by sterlind on Saturday March 07, 2020 @03:40AM
(#22510615)
Not an expert, but creating a perennial vaccine depends on the mutation rate and which highly-conserved regions can be targeted.
One of the potential vaccines enrolling trial patients is made of mRNA that codes for the spike protein needed for entry to cells. [0] If that spike protein turns out to be highly-conserved, then the vaccine will have sticking power. If it's not, but there turn out to be evolutionary trade-offs to adapting around it, it could push the virus to become less aggressive.